A Phase 1 Study of the Pharmacokinetics (PK) and Safety of Pomalidomide + Low Dose Dexamethasone (POM+LODEX) in Patients (PTS) With Relapsed or Refractory Multiple Myeloma (RRMM) and Renal Impairment (RI)

J. Matous; D. Siegel; S. Lonial; R. Donald Harvey; C. Kasserra; Y. Li; M. Chen; T. Doerr; L. Sternas; M. Zaki; C. Jacques; J. Shah

doi:10.1016/J.CLML.2015.07.557

A Phase 1 Study of the Pharmacokinetics (PK) and Safety of Pomalidomide + Low Dose Dexamethasone (POM+LODEX) in Patients (PTS) With Relapsed or Refractory Multiple Myeloma (RRMM) and Renal Impairment (RI)

J. Matous
, D. Siegel
, S. Lonial
, R. Donald Harvey
, C. Kasserra
, Y. Li
, M. Chen
, T. Doerr
, L. Sternas
, M. Zaki
, C. Jacques
, J. Shah

Colorado Blood Cancer Institute, Denver, Colorado, USA
Hackensack University Medical Center
Emory University
Celgene
University of Texas MD Anderson Cancer Center

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Clinical Lymphoma, Myeloma & Leukemia
Volume	15
DOIs	https://doi.org/10.1016/J.CLML.2015.07.557
State	Published - Sep 1 2015
Externally published	Yes

Disciplines

Pharmacology
Medicine and Health Sciences

Access to Document

10.1016/J.CLML.2015.07.557License: Unspecified

Cite this

Matous, J., Siegel, D., Lonial, S., Harvey, R. D., Kasserra, C., Li, Y., Chen, M., Doerr, T., Sternas, L., Zaki, M., Jacques, C., & Shah, J. (2015). A Phase 1 Study of the Pharmacokinetics (PK) and Safety of Pomalidomide + Low Dose Dexamethasone (POM+LODEX) in Patients (PTS) With Relapsed or Refractory Multiple Myeloma (RRMM) and Renal Impairment (RI). Clinical Lymphoma, Myeloma & Leukemia, 15. https://doi.org/10.1016/J.CLML.2015.07.557

A Phase 1 Study of the Pharmacokinetics (PK) and Safety of Pomalidomide + Low Dose Dexamethasone (POM+LODEX) in Patients (PTS) With Relapsed or Refractory Multiple Myeloma (RRMM) and Renal Impairment (RI). / Matous, J.; Siegel, D.; Lonial, S. et al.
In: Clinical Lymphoma, Myeloma & Leukemia, Vol. 15, 01.09.2015.

Research output: Contribution to journal › Article › peer-review

Matous, J, Siegel, D, Lonial, S, Harvey, RD, Kasserra, C, Li, Y, Chen, M, Doerr, T, Sternas, L, Zaki, M, Jacques, C & Shah, J 2015, 'A Phase 1 Study of the Pharmacokinetics (PK) and Safety of Pomalidomide + Low Dose Dexamethasone (POM+LODEX) in Patients (PTS) With Relapsed or Refractory Multiple Myeloma (RRMM) and Renal Impairment (RI)', Clinical Lymphoma, Myeloma & Leukemia, vol. 15. https://doi.org/10.1016/J.CLML.2015.07.557

@article{e9ac2c867c8e41e8a74affbccec1b4ff,

title = "A Phase 1 Study of the Pharmacokinetics (PK) and Safety of Pomalidomide + Low Dose Dexamethasone (POM+LODEX) in Patients (PTS) With Relapsed or Refractory Multiple Myeloma (RRMM) and Renal Impairment (RI)",

author = "J. Matous and D. Siegel and S. Lonial and Harvey, \{R. Donald\} and C. Kasserra and Y. Li and M. Chen and T. Doerr and L. Sternas and M. Zaki and C. Jacques and J. Shah",

year = "2015",

month = sep,

day = "1",

doi = "10.1016/J.CLML.2015.07.557",

language = "American English",

volume = "15",

journal = "Clinical Lymphoma, Myeloma \& Leukemia",

}

TY - JOUR

T1 - A Phase 1 Study of the Pharmacokinetics (PK) and Safety of Pomalidomide + Low Dose Dexamethasone (POM+LODEX) in Patients (PTS) With Relapsed or Refractory Multiple Myeloma (RRMM) and Renal Impairment (RI)

AU - Matous, J.

AU - Siegel, D.

AU - Lonial, S.

AU - Harvey, R. Donald

AU - Kasserra, C.

AU - Li, Y.

AU - Chen, M.

AU - Doerr, T.

AU - Sternas, L.

AU - Zaki, M.

AU - Jacques, C.

AU - Shah, J.

PY - 2015/9/1

Y1 - 2015/9/1

UR - https://www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650(15)00989-1/fulltext

U2 - 10.1016/J.CLML.2015.07.557

DO - 10.1016/J.CLML.2015.07.557

M3 - Article

VL - 15

JO - Clinical Lymphoma, Myeloma & Leukemia

JF - Clinical Lymphoma, Myeloma & Leukemia

ER -

A Phase 1 Study of the Pharmacokinetics (PK) and Safety of Pomalidomide + Low Dose Dexamethasone (POM+LODEX) in Patients (PTS) With Relapsed or Refractory Multiple Myeloma (RRMM) and Renal Impairment (RI)

Disciplines

Access to Document

Other files and links

Cite this